Stock Rating Upgrade
The Value Trend Rating for Novo Nordisk A/S (NYSE: NVO) improved of late from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
On 1/12/24, Novo Nordisk A/S (NYSE: NVO) stock rose modestly by 0.4%, closing at $107.16. This advance was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong over the last nine months but is unchanged during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, NVO is expected to continue to be a major Value Builder.
Novo Nordisk A/S has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Novo Nordisk A/S has a slightly negative Appreciation Score of 39 but a very high Power Rating of 88, producing the Positive Value Trend Rating.
Be the first to comment